Nurix Therapeutics Inc. (NRIX)
undefined
undefined%
At close: undefined
20.27
0.30%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 76.99M 38.63M 29.75M 17.82M 31.11M 37.45M
Cost of Revenue 189.15M 10.81M 6.08M 66.49M 45.02M 40.51M
Gross Profit -112.16M 27.82M 23.67M -48.67M -13.91M -3.06M
Operating Income -155.06M -183.87M -117.89M -64.98M -22.24M -9.74M
Interest Income 11.12M 3.51M 823.00K 1.21M 776.00K 818.00K
Pretax Income -143.95M -180.36M -117.06M -63.78M -21.46M -8.92M
Net Income -143.95M -166.04M -117.19M -43.24M -21.70M -9.43M
Selling & General & Admin 42.90M 38.00M 31.20M 16.31M 8.33M 6.67M
Research & Development 189.15M 184.50M 116.43M 66.49M 45.02M 40.51M
Other Expenses - - - - - -
Operating Expenses 232.05M 222.49M 147.64M 82.80M 53.35M 47.19M
Interest Expense - - - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 232.05M 222.49M 147.64M 82.80M 53.35M 47.19M
Income Tax - -14.31M 131.00K -20.54M 239.00K 507.00K
Shares Outstanding (Basic) 54.34M 48.61M 42.90M 15.67M 38.85M 16.11M
Shares Outstanding (Diluted) 54.34M 48.61M 42.90M 15.67M 38.85M 16.11M
EPS (Basic) -2.65 -3.42 -2.73 -2.76 -0.56 -0.59
EPS (Diluted) -2.65 -3.42 -2.73 -2.76 -0.56 -0.59
EBITDA -141.41M -173.06M -111.80M -62.80M -19.88M -6.75M
Depreciation & Amortization 13.65M 10.81M 6.08M 2.18M 2.35M 2.99M